Hyperparathyroidism, Parathyroid Hormone and Calcium Flashcards

1
Q

Primary Hyperparathyroidism - Causes

A

In exams, primary hyperparathyroidism is stereotypically seen in elderly females with an unquenchable thirst and an inappropriately normal or raised parathyroid hormone level. It is most commonly due to a solitary adenoma

Causes of primary hyperparathyroidism 
80%: solitary adenoma
15%: hyperplasia
4%: multiple adenoma
1%: carcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Primary Hyperparathyroidism - Features

A

Features - ‘bones, stones, abdominal groans and psychic moans’
polydipsia, polyuria
peptic ulceration/constipation/pancreatitis
bone pain/fracture
renal stones
depression
hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Primary Hyperparathyroidism - Associations

A

Associations

  • hypertension
  • multiple endocrine neoplasia: MEN I and II
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Primary Hyperparathyroidism - Ix

A

Investigations
raised calcium, low phosphate
PTH may be raised or normal
technetium-MIBI subtraction scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Primary Hyperparathyroidism - Mx

A

Total Parathyroidectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Secondary Hyperparathyroidism - At what level of PTH would you begin supplementation with calcium and vitamin D?

A

Supplementing calcium and vitamin D in secondary hyperparathyroidism runs the risk of adynamic bone disease if this is begun at less than twice the upper limit of the normal range for PTH. For this reason levels are usually tracked until they cross this threshold, where upon supplementation is commenced. In the event that patients with PTH levels greater than twice the upper limit of normal are left untreated, there is significant risk of progression to tertiary disease, and increased propensity to complications associated with hyperparathyroidism including bone resorption, fracture and ectopic calcification.

Example Question:
A 62-year-old woman with a history of type 1 diabetes and end stage renal failure comes to the renal clinic for review. Over the past few months she has been feeling increasingly lethargic with proximal muscle pains and weakness. She is managed with a basal bolus insulin regime, Examination reveals a blood pressure of 155/82 mmHg, pulse is 70 beats per minute and regular. Chest is clear, there is no ankle swelling. Abdomen is soft and non-tender. You confirm proximal muscle weakness.

Investigations

Hb	101 g/l	
Na+	137 mmol/l	
Bilirubin	11 µmol/l
Platelets	95 * 109/l	
K+	3.7 mmol/l	
ALP	185 u/l
WBC	8.4 * 109/l	
Urea	13.2 mmol/l	
ALT	23 u/l
Neuts	5.1 * 109/l	
Creatinine	382 µmol/l	
γGT	57 u/l
Lymphs	2.1 * 109/l	
Ca++	2.1 mmol/l	
Albumin	30 g/l

You suspect that she has secondary hyperparathyroidism. At what level of PTH would you begin supplementation with calcium and vitamin D?

	In the normal range
	Just above the normal range
	> Twice the normal range
	Three times the normal range
	Four times the normal range
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hypercalcaemia - Causes

A

Hypercalcaemia: causes

The most common causes of hypercalcaemia are malignancy (bone metastases, myeloma, PTHrP from squamous cell lung cancer) and primary hyperparathyroidism

Other causes include
sarcoidosis*
vitamin D intoxication
acromegaly
thyrotoxicosis
Milk-alkali syndrome
drugs: thiazides, calcium containing antacids
dehydration
Addison's disease
Paget's disease of the bone**

*other causes of granulomas may lead to hypercalcaemia e.g. Tuberculosis and histoplasmosis

**usually normal in this condition but hypercalcaemia may occur with prolonged immobilisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hypercalcaemia - Example Question

A

A 56-year-old lady presents with a 3 month history of abdominal pains, low mood and constipation. Past medical history includes hypertension and depression following the death of her husband 2 years ago. Routine blood tests are performed by the GP and upon review the patient is referred into hospital.

Blood tests are as below:

Hb	100 g/l	
Na+	135 mmol/l
Platelets	230 * 109/l	
K+	4.7 mmol/l
WBC	10 * 109/l	
Urea	6 mmol/l
Calcium (adjusted)	2.96 mmol/l	
Creatinine	110 µmol/l
Phosphate	1.35 mmol/l	
CRP	30 mg/l
Albumin	35 g/L		

Which diagnostic test should be performed first?

	> Parathyroid hormone level
	Myeloma screen
	CT chest, abdomen and pelvis
	Urinary calcium levels
	Skeletal X-ray

The two main causes of hypercalcaemia are primary hyperparathyroidism and malignancy. Parathyroid hormone level will help to differentiate between these two main differentials and help guide further investigations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hyperparathyroidism - Hand Radiograph - Example Description

A

Bilateral hand radiographs in a middle-aged woman demonstrating generalised osteopenia, erosion of the terminal phalangeal tufts (acro-osteolysis) and subperiosteal resorption of bone particularly the radial aspects of the 2nd and 3rd middle phalanges. These changes are consistent with a diagnosis of hyperparathyroidism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Primary Hyperparathyroidism - Monitoring: Example Question

A

A 44-year-old woman is admitted to hospital complaining of a swollen breast for three days. She is otherwise well, having no medical problems. She is diagnosed by the surgical team with a breast abscess, which is drained and she is started on antibiotic treatment. Before being discharged, she is found to have elevated corrected calcium (2.79 mmol/L) and elevated parathyroid hormone (9.5 pmol/L).

She is reviewed by the endocrine team. She does not have any symptoms apart from those related to her breast abscess, and additional examination is unremarkable. Further tests are requested, showing that vitamin D levels are normal, 24-hour urine calcium is normal, and a DEXA scan is normal as well. She is advised to see her GP for annual blood tests for calcium levels and renal function.

She is diagnosed with primary hyperparathyroidism. What additional investigation should be used to monitor her?

	24-hour urine calcium annually
	Breast ultrasound annually
	Abdominal X-ray annually
	Abdominal ultrasound every three years
	> DEXA scan every one to two years

The correct answer is a DEXA scan. This patient has been incidentally found to have primary hyperparathyroidism and has no evidence of indications for parathyroidectomy. Monitoring should include renal function and DEXA scanning to identify any decline in renal function, worsening hypercalcaemia or osteoporosis. Any of these changes would be indications for surgery. Abdominal X-rays and ultrasound scanning may be useful in the acute setting to detect renal stones but are not recommended as monitoring. Urinary calcium useful at diagnosis to exclude hypocalciuric hypercalcaemia.

Source:

‘Hypercalcaemia.’ Clinical Knowledge Summaries. National Institute for Health and Care Excellence, Dec. 2014.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Primary Hyperparathyroidism - Diagnosis and Mx: Example Question

A

A 45-year-old gentleman presents to clinic for review. Two weeks ago he presented to the emergency department with renal colic. A spiral CT KUB confirmed nephrolithiasis and he was managed conservatively with IV fluids, analgesia and an alpha-blocker. His symptoms resolved entirely and he was discharged.

Blood tests:
Hb	142 g/l
Platelets	329 * 109/l
WBC	6.6 * 109/l
Na+	141 mmol/l
K+	3.8 mmol/l
Urea	6.2 mmol/l
Creatinine	71 µmol/l
Corrected calcium	2.71 mmol/l
Parathyroid hormone	10.2 pmol/l
Urine tests (24-hour collection):
Urinary calcium	183 mg

How should he be further managed?

	Annual monitoring of calcium and renal function
	Encourage oral fluids
	Bisphosphonates
	Vitamin D supplementation
	> Parathyroidectomy

The correct answer is parathyroidectomy. This is a patient who has developed renal colic secondary to likely primary hyperparathyroidism, as is suggested by his hypercalcaemia and elevated parathyroid hormone. The mainstay of management of primary hyperparathyroidism is parathyroidectomy, but cases have to be appropriately identified as surgical candidates. This patient developed renal stones as a likely complication and therefore would benefit from surgery. If the blood tests been an incidental finding, then monitoring and oral fluids both would have been more appropriate.

Source:

‘Hypercalcaemia.’ Clinical Knowledge Summaries. National Institute for Health and Care Excellence, Dec. 2014

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pseudohyperparathyroidism

A

Pseudohypoparathyroidism

Pseudohypoparathyroidism is caused by target cell insensitivity to parathyroid hormone (PTH) due to a mutation in a G-protein. In type I pseudohypoparathyroidism
there is a complete receptor defect whereas in type II the cell receptor is intact. Pseudohypoparathyroidism is typically inherited in an autosomal dominant fashion*

Bloods
PTH: high
calcium: low
phosphate: high

Features
short fourth and fifth metacarpals
short stature
cognitive impairment
obesity
round face

Investigation
infusion of PTH followed by measurement of urinary phosphate and cAMP measurement - this can help differentiate between type I (neither phosphate or cAMP levels rise) and II (cAMP rises but phosphate levels do not change)

*it was previously thought to be an X-linked dominant condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pseudohyperparathyroidism Type 1a - Example Question

A

A surgical Foundation Year 1 doctor (FY1) asks you to review a preoperative ECG for a 19-year-old patient who has been admitted under their team with suspected appendicitis. The only abnormality is a prolonged QT and you note the adjusted calcium to be 2.02 mmol/l.

The FY1 tells you that when they looked at the patients closed fists the outer two knuckles looked like dimples. She also tells you that the patient’s body mass index is 29 kg/m².

You ask her to order some blood tests which come back as follows:

Adjusted calcium 2.02 mmol/l
PTH 69 pmol/L (normal range = 0.8 - 8.5)
Phosphate 2.0 mmol/l
ALP 130 u/l

What is the most likely underlying cause for this patient’s hypocalcaemia?

	Hypoparathyroidism
	> Pseudohypoparathyroidism type 1a
	Pseudohypoparathyroidism type 1b
	Pseudopseudohypoparathyroidism
	Secondary hyperparathyroidism

This patient has a high PTH, a low calcium, a high phosphate and a normal ALP. The patient is also obese and the dimples on the outer two knuckles are likely to represent shortening of the 4th and 5th metacarpals. This biochemistry in combination of these clinical features is characteristic of pseudohypoparathyroidism Type 1a (Albright’s Hereditary Osteodystrophy).

Pseudopseudohypoparathyroidism would have the same clinical features but would have normal biochemistry. Pseudohypoparathyroidism Type 1b would have the same biochemistry but lack the clinical features.

This patient has a high PTH, therefore this immediately excludes hypoparathyroidism. In secondary hyperparathyroidism the ALP would be elevated therefore this is incorrect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Post Parathyroidectomy Cx - Hypocalcaemia: Example Question

A

A 50-year-old woman with a history of Grave’s disease is reviewed on the surgical ward some 12hrs after parathyroidectomy. She has begun suffering from episodes of carpopedal spasm and pins and needles affecting both hands and around her mouth. On examination on the ward, her blood pressure is 115/72 mmHg, and pulse is 88 beats per minute. Her serum calcium is measured at 1.85 mmol/l.

Which of the following is the most appropriate intervention?

	Intravenous diazepam
	> Intravenous calcium
	Intravenous magnesium
	Oral calcium
	Oral vitamin D

This patient has symptomatic hypocalcaemia, most likely due to an acute fall in parathyroid hormone after surgery. This is considered a medical emergency and calcium replacement IV is essential:

IV calcium gluconate is administered initially with 20 ml of 10% calcium gluconate in 50-100 ml of 5% dextrose IV, given over 10 minutes with ECG monitoring.This can be repeated until the patient is asymptomatic. It should be followed up with a calcium gluconate infusion where 100ml of 10% calcium gluconate is diluted in 1 litre of normal saline or 5% dextrose and infused at 50-100 ml/hr.

Not intervening with respect to the electrolyte disturbance risks significant sequelae including cardiac arrhythmia, diazepam is therefore not appropriate. IV magnesium is most useful where hypocalcaemia is resistant to correction, and oral interventions would take too long to elevate serum calcium levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hungry Bone Syndrome

A

Hungry bone syndrome

Hungry bone syndrome is an uncommon entity but can occur after parathyroidectomy if the hyperparathyroidism has been long standing. The mechanism is thought to be thus: high pre-operative levels of parathyroid hormone provide a constant stimulus for osteoclast activity creating the hypercalcaemic state by de-mineralizing the bones. This process can result in x-ray changes very similar to metastatic lytic lesions if left untreated. Upon removal of the parathyroid adenoma the hormone levels fall rapidly (they have a very short half life) and the osteoclast activity is subsequently diminished and the bones rapidly begin re-mineralisation - ‘hungry bone syndrome’. This process can be uncomfortable and also result in systemic hypocalcaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hungry Bone Syndrome - Example Question

A

You are asked to review a 67-year-old man who is currently an inpatient on a surgical ward with new paraesthesia in his fingers. He was admitted for an elective parathyroidectomy three days ago for fairly long standing hyperparathyroidism and subsequent hypercalcaemia. He had a single parathyroid adenoma excised which had been identified on pre-operative MIBI scanning. The procedure was without complications but he is now complaining of a tingling sensation in his fingers that he first noticed about twelve hours ago. He also complains of new severe pain in both of his ankles which is worse when he walks, but also present at rest. The surgical SHO has already arranged x-rays of the patient’s ankles and these reveal multiple osteolytic lesions which have been reported as being suspicious for metastatic disease. He is otherwise fit and well and his only regular medications are paracetamol, tramadol and prophylactic dalteparin. His blood tests are as follows.

Adjusted Calcium 1.84 mmol/L
Magnesium 0.7 mmol/L

What is the most likely explanation for his current symptoms?

	Metastatic parathyroid cancer
	Secondary hyperparathyroidism
	Hypomagnesaemia
	> Hungry bone syndrome
	Secondary hypoparathyroidism

Hypocalcaemia after parathyroid surgery is relatively common and usually ‘benign’ and associated with a transient hypoparathyroidism. However, it can sometimes be more marked and give rise to symptoms such as perioral or finger paraesthesia. This state alone would not, however, explain his ankle pain or x-ray findings.

Although hypomagnesaemia may also be present and should be treated, it does not explain the symptoms. Metastatic parathyroid cancer is a possibility given the x-ray findings, but is very uncommon and is less likely given that his hyperparathyroidism and hypercalcaemia was long standing (i.e. indolent). Secondary hyperparathyroidism is the syndrome of appropriately raised parathyroid hormone in response to hypocalcaemia, usually secondary to chronic kidney disease. Secondary hypoparathyroidism describes the normal parathyroid hormone suppression that occurs in hypercalcaemia secondary to non-parathyroid causes, such as malignancy.

17
Q

Hypercalcaemia - Diagnosis: Example Question

A

A 60-year-old man attends a medical health check-up at his GP surgery. He was fit and well with a past medical history of childhood asthma and osteoarthritis in his fingers. His observations were included a blood pressure of 129/80 mmHg, pulse of 82 bpm, and oxygen sats of 97%.

Blood tests were performed and revealed:

Hb 138 g/l 
Platelets 190 * 109/l 
WBC 7.6 * 109/l 
Na+ 139 mmol/l 
K+ 3.9 mmol/l 
Urea 4.1 mmol/l 
Creatinine 9.2 µmol/l 
Bilirubin 15 µmol/l 
ALP 52 u/l 
ALT 26 u/l 
γGT 58 u/l 
Albumin 40 g/l 
Serum corrected calcium 2.77 mmol/L 
Serum phosphate 0.90 mmol/l 
Parathyroid hormone 5.9 pmol/L normal range 1.2-5.8 pmol/L 

A 24 hour urinary calcium test was performed based on the results above and revealed a result of 0.5 mmol/24 hours (normal range 2.4-7.4 mmol/24 hours)

What is the most likely diagnosis?

 Primary hyperparathyroidism 
 Secondary hyperparathyroidism 
 Vitamin D toxicity 
 Multiple endocrine neoplasia type A 
 > Familial benign hypocalciuric hypercalcaemia 

The most likely diagnosis in this scenario is familial benign hypocalciuric hypercalcaemia. Most cases are asymptomatic and blood test reveals hypercalcaemia with a reduced calcium urinary excretion rate (of under 0.02 mmol/L). There may also be normal to high parathyroid hormone, despite the elevated serum calcium levels.

18
Q

Hyperparathyroidism Diagnosis - Example Question

A

A 60-year- old female presented with a six month history of polyuria, polydipsia and generalised aches and pains.

She is a known hypertensive for ten years and is taking bendroflumethiazide 2.5 mg daily. She has been taking calcium and vitamin D supplements for the last two years as she has a strong family history of osteoporosis.

On examination, her pulse rate is 80 beats per minute and her blood pressure is 150/90 mmHg. Cardiovascular, respiratory and abdominal examination were normal.

Investigations reveal:

Serum sodium	130 mmol/L
Serum potassium	3.1 mmol/L
Serum urea	7.7 mmol/L
Serum creatinine	88 mol/L
Serum corrected calcium	2.9 mmol/L
Phosphate	0.8 mmol/L
PTH	4.5 pmol/L (0.9-5.4)
Urinalysis	glycosuria ++

What is the most likely cause of this ladys symptoms?

	> Primary hyperparathyroidism
	Vitamin D excess
	Bendroflumethizide induced hypercalcaemia
	Familial hypocalciuric hypercalcaemia
	Diabetes mellitus

This lady has hypercalcaemia which may be due to bendroflumethiazide or vitamin D excess, but the PTH level is inappropriately normal in the context of hypercalcaemia which indicates primary hyperparathyroidism rather than any other cause of hypercalcaemia in which the PTH would be suppressed by homeostatic mechanisms.

In addition, the phosphate level is low which is typical of primary hyperparathyroidism. The glycosuria is a distractor.

19
Q

Primary Hyperthyroidism - Example Question

A

A 47-year-old woman is admitted to the surgical ward with severe loin to groin abdominal pain. A CT-KUB reveals a right-sided renal calculus. When you clerk her in she admits to you that she has not felt herself for the past few weeks with polyuria, polydipsia, constipation and altered mood.

Blood tests show:

Estimated glomerular filtration rate >60 ml/min
Adjusted calcium 3.1 mmol/l (2.1-2.6 mmol/l)
Phosphate 0.6 mmol/l (0.8-1.4 mol/l)
Parathyroid hormone 5.1 pmol/l (1.2-5.8 pmol/l)

Which of the following is the most likely cause for her symptoms?

	> Primary hyperparathyroidism
	Secondary hyperparathyroidism
	Sarcoidosis
	Tertiary hyperparathyroidism
	Type 1 renal tubular acidosis

The most likely diagnosis here is primary hyperparathyroidism caused by parathyroid adenoma or hyperplasia. The classical biochemical findings are a high serum calcium and low phosphate. The parathyroid hormone level is either high or inappropriately normal.

Secondary hyperparathyroidism is caused by chronic hypocalcaemia (e.g. chronic kidney disease). Serum calcium is low or normal whilst parathyroid hormone levels are high.

Tertiary hyperparathyroidism develops from secondary hyperparathyroidism and results in autonomous parathyroid production. It is usually seen patients with end-stage renal disease.

Sarcoidosis and type 1 renal tubular acidosis are rare causes of hypercalcaemia.

20
Q

Hypercalcaemia - Example Question

A

A 45-year-old lady is admitted to hospital with abdominal pain and malaise. She has no past medical history and takes no regular medications or supplements. Bloods tests show:

Ca 2++ 2.70 mmol/l
PO4 + 1.2 mmol/l
Creatinine 60 µmol/l

Chest X-ray - normal appearances

She denies taking any medications or supplements. Her chest X-ray is normal in appearance,and renal function normal. You ring the GP and find out her calcium was also slightly raised 8 years ago. What is the most likely diagnosis?

	Secondary hyperparathyroidism
	Malignancy with bony metastasis
	Primary hyperparathyroidism
	> Familial hypocalciuric hypercalcaemia
	Sarcoidosis

PO4 would normally be low in primary hyperparathyroidism. Her renal function is normal excluding secondary hyperparathyroidism. Sarcoidosis is unlikely with a normal CXR. This leaves malignancy or familial hypocalciuric hypercalcaemia. Although malignancy is possible her raised Ca2+ 8 years makes familial hypocalciuric hypercalcaemia more likely.

21
Q

Hypercalcaemia - Example Question

A

A 60-year-old man attends a medical health check-up at his GP surgery. He was fit and well with a past medical history of childhood asthma and osteoarthritis in his fingers. His observations were included a blood pressure of 129/80 mmHg, pulse of 82 bpm, and oxygen sats of 97%.

Blood tests were performed and revealed:

Hb 138 g/l 
Platelets 190 * 109/l 
WBC 7.6 * 109/l 
Na+ 139 mmol/l 
K+ 3.9 mmol/l 
Urea 4.1 mmol/l 
Creatinine 9.2 µmol/l 
Bilirubin 15 µmol/l 
ALP 52 u/l 
ALT 26 u/l 
γGT 58 u/l 
Albumin 40 g/l 
Serum corrected calcium 2.77 mmol/L 
Serum phosphate 0.90 mmol/l 
Parathyroid hormone 5.9 pmol/L normal range 1.2-5.8 pmol/L 

A 24 hour urinary calcium test was performed based on the results above and revealed a result of 0.5 mmol/24 hours (normal range 2.4-7.4 mmol/24 hours)

What is the most likely diagnosis?

 Primary hyperparathyroidism 
 Secondary hyperparathyroidism 
 Vitamin D toxicity 
 Multiple endocrine neoplasia type A 
>  Familial benign hypocalciuric hypercalcaemia 

The most likely diagnosis in this scenario is familial benign hypocalciuric hypercalcaemia. Most cases are asymptomatic and blood test reveals hypercalcaemia with a reduced calcium urinary excretion rate (of under 0.02 mmol/L). There may also be normal to high parathyroid hormone, despite the elevated serum calcium levels.

22
Q

Hypercalcaemia - Example Question

A

A 50-year-old female is referred to the clinic with hypercalcaemia found coincidentally during routine investigations. On further questioning she admits that she is taking a lot of antacid preparations (for her reflux oesophagitis) and calcium and vitamin D for protection against osteoporosis as her mother and sister have osteoporosis for which they are taking alendronate.

On examination there were no relevant findings.

Investigations reveal:

Serum sodium	135 mmol/L
Serum potassium	3.5 mmol/L
Serum urea	4.2 mmol/L
Serum creatinine	77 mol/L
Serum calcium	2.8 mmol/L
Serum phosphate	0.8 mmol/L
Plasma PTH	5.4 pmol/L (0.9-5.4)
24-h urinary calcium	1.5 mmol/24hr (2.5-7.5)

What is the most likely diagnosis?

	Primary hyperparathyroidism
	Milk- alkali syndrome
	Hypervitaminosis D
	> Familial hypocalciuric hypercalcaemia
	Tertiary hyperparathyroidism

Familial hypocalciuric hypercalcaemia is an autosomal dominant disease characterized by asymptomatic hypercalcaemia with hypocalciuria and a normal PTH level. Most cases are discovered incidentally.

23
Q

Parathyroid Hormone

A

PTH secreted by parathyroid glands

NET EFFECTS OF PTH:

  • Increase in serum Ca2+
  • Decrease in serum phosphate

1) PTH > causes decreased excretion of Ca2+ by the kidneys
> Increase in Calcium in the serum

2) PTH `> causes increase in rate of Ca2+ and phosphate absorption from bone (caused by PTH action on osteocytes)
3) PTH > causes increased excretion of phosphate by the kidneys > decreases serum phosphate
4) PTH > increases the calcium and phosphate absorption from the gut

24
Q

Differentiating between Primary, Secondary and Tertiary Hyperparathyroidism

A

Hyperparathyroidism (HPT) results when there is excessive secretion of parathyroid hormone (PTH).PTH is secreted by the four parathyroid glands, located in the neck behind the thyroid gland. It regulates serum calcium and phosphate levels and also plays a part in bone metabolism. High levels of PTH cause serum calcium levels to increase and serum phosphate levels to fall.

HPT may be:

Primary - one parathyroid gland (or more) produces excess PTH. This may be asymptomatic.

Secondary - there is increased secretion of PTH in response to low calcium because of kidney, liver, or bowel disease.

Tertiary - there is autonomous secretion of PTH, usually because of chronic kidney disease (CKD).

25
Q

A Reminder of Calcium and PTH Homeostasis

A

A reminder of calcium and phosphate homeostasis:

Maintenance of normal serum calcium levels involves the regulation of the flux of calcium between the intestinal tract, kidneys and bone.
Calcium itself, PTH and 1,25-dihydroxyvitamin D3 (calcitriol) all play a role in calcium regulation.
Calcitonin (produced by C cells of the thyroid) can also affect calcium homeostasis. It inhibits osteoclast activity and reduces the release of calcium and phosphate from bone.

PTH:

  • Increases the release of calcium from bone matrix.
  • Increases calcium reabsorption by the kidney.
  • Increases phosphate excretion.
  • Increases renal production of 1,25-dihydroxyvitamin D3, which increases intestinal absorption of calcium.
  • High concentrations of serum calcium inhibit PTH secretion, while low concentrations stimulate it.
26
Q

Primary Hyperparathyroidism

A

Primary hyperparathyroidism

Epidemiology

  • Primary hyperparathyroidism (PHPT) is the third most common endocrine disorder.
  • It is most common in postmenopausal women.

Causes:
- Excess PTH is produced by one or more of the parathyroid glands, due to:
A single parathyroid gland adenoma (85% of cases).
4-gland hyperplasia (10-15%).
Double adenomas (3-5%).
Parathyroid carcinoma (less than 1%).

  • Familial cases can occur as part of the multiple endocrine neoplasia syndromes (MEN 1 or MEN 2a), hyperparathyroid-jaw tumour (HPT-JT) syndrome, or familial isolated hyperparathyroidism (FIHPT).

Presentation
70-80% of people are asymptomatic and diagnosis is made after incidental hypercalcaemia is found. In those who are symptomatic, remember: ‘bones, stones, abdominal groans, and psychic moans’.

Clinical features are due to:

Excessive calcium resorption from bone:
Osteopenia and osteoporosis, presenting as bone pain and pathological fractures.
Osteitis fibrosa cystica can occur in severe cases. It presents with subperiosteal resorption of the distal phalanges, tapering of the distal clavicles, salt and pepper appearance of the skull, and brown tumours of the long bones.

Excessive renal calcium excretion:
Renal calculi (the most common presentation).

Hypercalcaemia:
Muscle weakness, proximal myopathy, fatigue.
Anorexia; nausea and vomiting; constipation; abdominal pain; peptic ulcer disease (hypercalcaemia can increase gastric acid secretion); acute pancreatitis.
Polyuria, polydipsia, dehydration.
Renal colic, haematuria, hypertension.
Long-standing hypercalcaemia causes corneal calcification, which is usually asymptomatic.
Neuropsychiatric manifestations are particularly common and may include depression, dementia, confusion, inability to concentrate and memory problems.
Hypertension, shortened QT interval on ECG and cardiac arrhythmias (rare).
Severe cases may lead to coma and death.

Differential diagnosis

Familial benign (hypocalciuric) hypercalcaemia (FBHH) - presents with hypercalcaemia and modestly raised or normal PTH. Autosomal dominant inheritance. A gene defect leads to inappropriate secretion of PTH at high serum calcium levels. Parathyroidectomy will be ineffective.

Lithium-induced hypercalcaemia.

Tertiary HPT.

Other causes of hypercalcaemia, especially malignancy; other causes include thyrotoxicosis, sarcoidosis, Paget’s disease of bone and Addison’s disease.

Investigations
PHPT is the most common cause of hypercalcaemia in many studies.

If someone presents with hypercalcaemia:
Look for any obvious drug causes (eg, lithium, thiazide diuretics).
Repeat plasma albumin-adjusted calcium levels.
Ensure renal function is normal.
Measure PTH, which will be raised in PHPT.

Findings

Hypercalcaemia.
Raised PTH.
Hypophosphataemia.
Mild-to-moderate increase in 24-hour urinary calcium excretion.

Other tests
25-hydroxyvitamin D (25(OH)D) should be measured if PTH raised; there is evidence that HPT is more active when patients are vitamin D-depleted. There is also evidence that raised PTH levels can reduce when low 25(OH)D levels are corrected.
Dual-energy X-ray absorptiometry (DEXA) scan can show any skeletal involvement in PHPT.
Pathognomonic X-ray changes include salt and pepper degranulation in the skull and subperiosteal bone resorption in the phalanges in severe cases.
Imaging of renal tract (X-ray, ultrasound) can demonstrate renal calculi.
A biopsy may be performed if carcinoma is suspected.

Mx:

Mild, asymptomatic disease
Surveillance can be used in patients with mildly elevated calcium levels and close to normal renal and bone status.

All patients should be replete in vitamin D, aiming for a minimum serum level of 25(OH)D >20 ng/dL. 800 to 1000 IU are a useful starting dose.
Such patients may continue for long periods without deterioration in bone mineral density.

However, progression can occur: at 15 years one third of patients will have overt features of HPT, such as kidney stones, worsening hypercalcaemia and reduced bone density.
Monitor for overt signs and symptoms of PHPT. However there is controversy over what constitutes ‘asymptomatic’, as the symptoms of PHPT can be nonspecific and subtle, such as fatigue, weakness and muscle pains.

Check serum creatinine level and calcium levels every six months.

3-site DEXA study should also be obtained every 1-2 years.

Avoid dehydration (advise a high fluid intake).

Avoid thiazide diuretics.

There is no recommendation to limit calcium intake.

Surgical treatment

Surgery offers the only potential for cure.
Parathyroid surgery to remove abnormal parathyroid gland(s) is suggested in most symptomatic patients. In the case of 4-gland hyperplasia, a 3.5-gland (subtotal) parathyroidectomy is performed.

Guidelines for the management of PHPT advise surgery if:
> Age is under 50.
> Serum albumin-adjusted calcium is more than 0.25 mmol/L (1 mg/dL) above the upper limit of normal (local laboratory reference).
> Creatinine clearance is <60 ml/minute.
> There is development of a kidney stone, either clinically or by imaging.
> Bone mineral density T score is less than -2.5 (at any site) or there is a significant reduction in bone mass density.
> There is a vertebral fracture.
> Patient request is also an appropriate indication, especially if follow-up is unlikely.
While there is subtle evidence that patients with PHPT may have cardiovascular dysfunction, there is no evidence that surgery for PHPT affects cardiovascular endpoints .

Minimally invasive parathyroidectomy in combination with pre-operative localisation investigations is increasingly being used. These investigations include ultrasound, MRI, computerised axial tomography and technetium 99m Tc-labelled sestamibi single-photon emission CT. However, they play no part in the diagnosis of PHPT.

Parathyroid surgery should only be performed by highly experienced surgeons .
Intraoperative measurement of PTH may also help to see if the abnormal gland(s) has been removed. The PTH level drops by 50% within 10-15 minutes of the hyper-functioning parathyroid tissue being removed.

Medical treatment

Medical management is used for those who opt against surgery or who do not meet the criteria for surgery.

Treatment is aimed at improving bone mineral density and achieving calcium homeostasis.

HRT and raloxifene may be used in postmenopausal women. They have been shown to reduce calcium levels as well as improve bone density. However, because of the risks associated with oestrogen replacement, it should not be used purely to treat PHPT.

Bisphosphonates (particularly alendronate) may be a useful treatment.

Cinacalcet reduces both serum calcium and PTH levels and raises serum phosphorus. Cinacalcet does not, however, reduce bone turnover or improve bone mineral density.

Complications after surgery
These include:
Hypocalcaemia - due to ‘hungry bone syndrome’. Calcium and phosphorus are rapidly deposited in bone. There is hypoparathyroidism and transient, sometimes severe, hypocalcaemia until the normal glands regain sensitivity. If hypoparathyroidism persists, calcium and vitamin D supplements are required.
Recurrent laryngeal nerve injury - suspect this if a patient develops new hoarseness postoperatively. Immediate laryngoscopy is indicated.
Haematoma formation - if this occurs in the pre-tracheal space, urgent evacuation is required before airway obstruction occurs.

Outcome after surgery
Successful parathyroid surgery leads to improved bone density, reduction in fracture incidence and fewer kidney stones, in those who have previously had them.
There may be improvements in some neurocognitive symptoms but this has not been confirmed with controlled trials.

27
Q

Secondary Hyperparathyroidism

A

Secondary hyperparathyroidism

Causes
Secondary hyperparathyroidism (SHPT) is most commonly seen in the setting of chronic kidney disease (CKD).
The parathyroid glands become hyperplastic after long-term stimulation in response to chronic hypocalcaemia.
It is seen in almost all patients with dialysis-dependent CKD. Most patients with CKD stage 5 develop SHPT .
Several studies have documented that PTH levels are increased in CKD (stages 3 and 4) before there are changes in calcium and phosphate.
It can, however, occur in any condition with chronic hypocalcaemia such as deficiency in vitamin D or malabsorption.

Presentation
Almost all patients with CKD have SHPT to some degree, so the clinical presentation is often that of kidney disease.
SHPT causes skeletal and cardiovascular complications in CKD patients.
If SHPT is due to vitamin D deficiency, the symptoms are mainly due to the vitamin deficiency (eg, osteomalacia with increased fracture risk, myopathy, etc).
In severe SHPT, bone pain may be present.
Calcium levels are low-normal; therefore, the symptoms related to hypercalcaemia seen with PHPT are absent.

Investigations
Findings:
Low-normal calcium.
Raised PTH.
Phosphate levels depend on aetiology (eg, high in renal disease, low in vitamin D deficiency).

Radiology can show evidence of bone disease and vascular and visceral calcification.

Treatment
Medical management is the mainstay of treatment.
The underlying condition needs to be treated - for example, correcting vitamin D deficiency.

Treatment in CKD includes:
Calcium supplementation.
Correction of vitamin D deficiency.
Phosphate restriction ± phosphate binders.
Vitamin D analogues.
Calcimimetics (eg, cinacalcet) may also be helpful.
The National Institute for Health and Care Excellence (NICE) only recommends the use of cinacalcet for those people with end-stage kidney disease whose SHPT is refractory to other treatment and in whom surgery is not suitable as a treatment.
Trials indicate that early intervention in stages 3 and 4 of CKD can correct PTH levels and could prevent renal bone disease, reduce cardiovascular complications and prolong patient survival.

Parathyroidectomy may be considered in severe cases refractory to medical treatment.

There is a 10% risk of recurrent or persistent disease after parathyroidectomy.

28
Q

Tertiary Hyperparathyroidism

A

Tertiary hyperparathyroidism
Causes
Tertiary hyperparathyroidism (THPT) usually occurs after prolonged SHPT.
The glands become autonomous, producing excessive PTH even after the cause of hypocalcaemia has been corrected.
This results in hypercalcaemia.

Long-standing kidney disease is the most common cause.

It can persist after a renal transplant.

Presentation
Symptoms and signs are due to hypercalcaemia so presentation can be similar to PHPT.
There are important health risks, particularly concerning bone density and the cardiovascular system.

Investigations
Findings:
Raised calcium
Raised PTH
Phosphate often raised

Treatment
Cinacalcet may be used in THPT.
Total or subtotal parathyroidectomy is the recommended treatment.
Autotransplantation of parathyroid tissue in an easily accessible site, such as the forearm, is also commonly carried out.

29
Q

Monitoring and Indications for Surgery in Primary Hyperparathyroidism

A

Monitoring should include renal function and DEXA scanning to identify any decline in renal function, worsening hypercalcaemia or osteoporosis. Any of these changes would be indications for surgery, as would renal colic as a Cx

30
Q

Pseudohyperparathyroidism Type Ia vs Type Ib vs Pseudopseudohyperparathyroidism

A

Pseudohyperparathyroidism Type Ia
High PTH, low calcium, high phosphate and normal ALP + obesity + dimples on outer two knuckles representing shortening of the 4th and 5th metacarpals. This biochemistry in combination of these clinical features is characteristic of pseudohypoparathyroidism Type 1a (Albright’s Hereditary Osteodystrophy).

Pseudohypoparathyroidism Type 1b would have the same biochemistry but lack the clinical features.

Pseudopseudohypoparathyroidism would have the same clinical features but would have normal biochemistry.

31
Q

How to differentiate between Primary Hyperparathyroidism and Familial Hypocalciuric Hypercalcaemia

A

Primary Hyperparathyroidism:

  • High Ca2+
  • Low phosphate
  • Hypercalciuria - calcium renal stones

Familial Hypocalciuric Hypercalcaemia

  • High Ca2+
  • NORMAL phosphate
  • Hypocalciuria
32
Q

CKD and Bone Disease

A

Basic Problems:

  • Low Vitamin D (1-alpha hydroxylation normally occurs in the kidneys)
  • High phosphate - due to decreased renal excretion
  • Low calcium - due to lack of vitamin , high phosphate
  • Secondary hyperparathyroidism - due to low calcium, high phosphate and low vitamin D

Several clinical manifestations may result!
Osteitis Fibrosa Cystica - aka hyperparathyroid bone disease
Adynamic - Reduction in cellular activity (both osteoclasts and osteoblasts) in bone, may be due to over treatment with vitamin d
Osteomalacia - due to low vitamin D
Osteosclerosis and Osteoporosis